CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market sale Chief Financial Officer sold 1,336 shares at $8.90 ($11,897)
- 4 Open-market sale Chief Scientific Officer sold 1,602 shares at $8.90 ($14,266)
- 4 Open-market sale CMO sold 3,254 shares at $8.90 ($28,977)
- 4 Open-market sale President and CEO sold 3,203 shares at $8.90 ($28,522)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 14 of 22 · 423 filings